July 6, 2010

Beckman Coulter and DNA Genotek Enhance DNA Isolation and Purification

Beckman Coulter Genomics today announced the development of a new version of the DNAdvance System for use with DNA Genotek’s Oragene®•DNA samples.

DNAdvance SP, from Beckman Coulter Genomics, is an extraction kit for the isolation and purification of DNA from saliva samples collected with DNA Genotek’s Oragene•DNA Self Collection Kits. The high throughput genomic DNA (gDNA) isolation reagent system enables the purification of high quality DNA from saliva samples, making it ideal for genotyping applications (SNP, fragment analysis), sequencing and qPCR. The system provides researchers and laboratories with an optimized and robust solution for DNA extraction and purification from saliva collected with Oragene•DNA Self Collection Kits.

Oragene•DNA is an all-in-one system for the collection, stabilization, transportation and purification of DNA from saliva that enables easy, reliable and cost effective collection of samples from large numbers of individuals while providing high quality DNA.

“We chose to develop DNAdvance SP for Oragene•DNA samples because more and more of our customers are using this proven, non-invasive collection method,” said Bassam El-Fahmawi, product manager, strategic marketing with Beckman Coulter Genomics. “Customers will see the benefits of the collaboration in the consistent, high quality results delivered by the system.”

“The development of the DNAdvance SP System is a clear sign of the growing interest in non-invasive DNA sample collection in the scientific community,” said Cindy MacCullough, vice president, marketing, DNA Genotek. “There is an increasing demand for automated extractions from our customer base, and the DNAdvance SP System provides a streamlined extraction process that delivers predictable, quality yields for Oragene•DNA.”

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represent about 80% of the company's 2009 revenue of $3.3 billion. For more information, visit www.beckmancoulter.com.

® Oragene is a registered trademark of DNA Genotek, Inc.